Mingyi Li

2.2k total citations
97 papers, 1.7k citations indexed

About

Mingyi Li is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mingyi Li has authored 97 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 21 papers in Oncology and 18 papers in Epidemiology. Recurrent topics in Mingyi Li's work include Medicinal plant effects and applications (10 papers), Biological Activity of Diterpenoids and Biflavonoids (8 papers) and Microwave Engineering and Waveguides (6 papers). Mingyi Li is often cited by papers focused on Medicinal plant effects and applications (10 papers), Biological Activity of Diterpenoids and Biflavonoids (8 papers) and Microwave Engineering and Waveguides (6 papers). Mingyi Li collaborates with scholars based in China, United States and Canada. Mingyi Li's co-authors include Runzhi Zhu, Jie Liu, Qingyu Zhang, Nianping Chen, Haili Huang, Huilai Miao, Min Hu, Juan Xia, Qingyu Zhang and Hana M. Weingartl and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Colloid and Interface Science.

In The Last Decade

Mingyi Li

90 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingyi Li China 27 919 335 270 246 220 97 1.7k
Rong Wu China 27 991 1.1× 272 0.8× 134 0.5× 368 1.5× 381 1.7× 129 2.3k
Xiaoyan Lu China 27 1.8k 2.0× 413 1.2× 301 1.1× 176 0.7× 258 1.2× 88 3.0k
Min Fu China 18 768 0.8× 315 0.9× 145 0.5× 257 1.0× 90 0.4× 63 1.6k
Wei Niu China 24 1.2k 1.3× 185 0.6× 261 1.0× 166 0.7× 482 2.2× 71 2.2k
Wu H China 24 954 1.0× 295 0.9× 245 0.9× 123 0.5× 148 0.7× 181 2.0k
Xuechun Li China 18 893 1.0× 369 1.1× 139 0.5× 111 0.5× 329 1.5× 48 2.0k
Binbin Cheng China 25 864 0.9× 271 0.8× 79 0.3× 161 0.7× 194 0.9× 70 1.5k
Ling Zhu Australia 36 2.0k 2.2× 238 0.7× 153 0.6× 236 1.0× 493 2.2× 141 3.9k
Hao Pan China 25 955 1.0× 203 0.6× 99 0.4× 310 1.3× 144 0.7× 62 1.8k
Cun Liu China 27 988 1.1× 550 1.6× 116 0.4× 111 0.5× 318 1.4× 103 1.9k

Countries citing papers authored by Mingyi Li

Since Specialization
Citations

This map shows the geographic impact of Mingyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyi Li more than expected).

Fields of papers citing papers by Mingyi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyi Li. The network helps show where Mingyi Li may publish in the future.

Co-authorship network of co-authors of Mingyi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyi Li. A scholar is included among the top collaborators of Mingyi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyi Li. Mingyi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wen, C. S. Tan, Zhaodi Jiang, et al.. (2025). Plasma membrane-associated ARAF condensates fuel RAS-related cancer drug resistance. Nature Chemical Biology. 21(8). 1226–1237. 5 indexed citations
2.
Ji, Jiamin, Zhaofeng Luo, Mingyi Li, et al.. (2025). Direct Peritoneal Resuscitation and Melatonin in the Treatment of Abdominal Sepsis‐Induced Lung Injury via Macrophage Metabolic Reprogramming. Journal of Pineal Research. 77(4). e70066–e70066. 1 indexed citations
4.
Liu, Guohua, et al.. (2024). REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer. Scientific Reports. 14(1). 13834–13834. 1 indexed citations
6.
Wang, Mengyao, Fang Wang, Zhi-Rui Lin, et al.. (2021). PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma. Oncogenesis. 10(1). 9–9. 25 indexed citations
7.
Yang, Yong‐Guang, et al.. (2021). Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells. BMC Complementary Medicine and Therapies. 21(1). 194–194. 11 indexed citations
8.
Li, Mingyi, et al.. (2019). Muscarinic M1 and M2 receptor subtypes play opposite roles in LPS-induced septic shock. Pharmacological Reports. 71(6). 1108–1114. 9 indexed citations
9.
Pan, Qunwen, Rongfeng Wang, Zitao Li, et al.. (2019). Microvesicles Derived from TGF-β1 Stimulated Hepatic Stellate Cells Aggravate Hepatocellular Injury. Stem Cells and Development. 28(16). 1128–1139. 4 indexed citations
10.
Shen, Hongliang, et al.. (2017). The prognostic value of vascular endothelial growth factor in patients with renal cell carcinoma: a systematic review of the literature and meta-analysis. Clinical and investigative medicine. 40(2). E40–E48. 8 indexed citations
11.
He, Yifeng, Lijun Xiang, Jian Zhang, et al.. (2017). Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells. World Journal of Gastroenterology. 23(34). 6242–6242. 19 indexed citations
12.
Huang, Renwei, et al.. (2016). Hepatic Stellate Cell‐Derived Microvesicles Prevent Hepatocytes from Injury Induced by APAP/H2O2. Stem Cells International. 2016(1). 8357567–8357567. 11 indexed citations
13.
Pickering, Bradley, Shaun Tyler, Gregory A. Smith, et al.. (2015). Identification of a Novel Afipia Species Isolated from an Indian Flying Fox. PLoS ONE. 10(4). e0121274–e0121274. 2 indexed citations
14.
Zhang, Qingyu, Jie Liu, Bin Liu, et al.. (2014). Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism. Scientific Reports. 4(1). 4628–4628. 67 indexed citations
15.
Yi, Yu, et al.. (2013). Observation of therapeutic efficacy and toxicity of Durogesic and OxyContin in radiotheraputic mucositis-induced pain. Guoji yiyao weisheng daobao. 19(14). 2109–2112. 1 indexed citations
16.
Lan, Daoliang, Cheng Tang, Mingyi Li, & Hua Yue. (2010). Screening and identification of differentially expressed genes from chickens infected with Newcastle disease virus by suppression subtractive hybridization. Avian Pathology. 39(3). 151–159. 9 indexed citations
17.
Li, Hong, et al.. (2010). Genomic analysis of new serotype strains of duck hepatitis virus isolated in China.. Zhongguo yufang shouyi xuebao. 32(7). 507–511. 1 indexed citations
18.
Liu, Hualei, Yan Lv, Weijian Huang, et al.. (2010). [Detection of molecular markers of amantadine resistance in swine influenza viruses by pyrosequencing].. PubMed. 50(3). 395–9. 2 indexed citations
19.
Wang, Fujun, et al.. (2010). Cloning and sequence analysis of ORF5 and Nsp2 genes of porcine reproductive and respiratory syndrome virus from some pig farms in 2007-2009. Journal of Northwest A&F University. 38(10). 7–14.
20.
Zhang, Bin, et al.. (2009). A duplex RT-PCR assay for simultaneous detection of H5 subtype avian influenza viruses and velogenic Newcastle disease virus.. 26(2). 24–28. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026